Screener
Revolution Medicines, Inc. RVMD Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s operating lease liabilities (total)?
- Revolution Medicines, Inc. (RVMD) reported operating lease liabilities (total) of $154.49M in Q2 2026.
- How has Revolution Medicines, Inc.'s operating lease liabilities (total) changed year-over-year?
- Revolution Medicines, Inc.'s operating lease liabilities (total) increased by 16.3% year-over-year, from $132.79M to $154.49M.
- What is the long-term trend for Revolution Medicines, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s operating lease liabilities (total) has grown at a 37.2% compound annual growth rate (CAGR), from $32.66M to $158.7M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.
Ask your AI about Revolution Medicines, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude